TCF7L2 polymorphism and cognitive test performance in cardiovascular disease.

Area of Science:

• Neuroscience
• Genetics
• Cardiology

Background:

• Cardiovascular disease (CVD) is a significant health concern in older adults.
• Cognitive impairment is a common comorbidity in individuals with CVD.
• The role of specific genetic factors, such as transcription factor 7-like 2 (TCF7L2), in CVD-related cognitive function is not fully understood.

Purpose of the Study:

• To investigate the association between TCF7L2 genotypes and cognitive function in older adults with CVD.
• To determine if specific TCF7L2 single nucleotide polymorphisms (SNPs) are linked to differences in cognitive performance.

Main Methods:

• 111 older adults with diagnosed CVD were recruited from cardiology clinics.
• Neuropsychological tests assessed various cognitive domains including global function, attention, executive function, processing speed, learning, memory, visuospatial skills, motor function, and language.
• TCF7L2 single nucleotide polymorphism rs7903146 genotyping was performed to categorize participants into TT, CT, or CC genotype groups.

Main Results:

• Participants with the TCF7L2 TT genotype (n=12) exhibited poorer performance on attention, executive function, and processing speed tests compared to CC (n=46) and CT (n=53) genotype groups.
• These cognitive differences persisted after controlling for diabetes status.
• No significant differences in demographic or medical variables were observed between genotype groups.

Conclusions:

• The TCF7L2 TT genotype is associated with impaired attention, executive function, and psychomotor speed in older adults with cardiovascular disease.
• These findings suggest a potential genetic predisposition to cognitive deficits in this patient population.
• Further research incorporating neuroimaging and glucose tolerance testing is recommended to elucidate the underlying biological mechanisms.